Benoit Chardon
Keine laufenden Positionen mehr
Vermögen: 300 766 $ am 31.05.2024
Profil
Benoit Chardon worked as Vice President-Global Marketing at GC Aesthetics Plc.
He also worked as Chief Commercial Officer at Allurion Technologies, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.04.2024 | 199 183 ( 0,42% ) | 300 766 $ | 31.05.2024 |
Ehemalige bekannte Positionen von Benoit Chardon
| Unternehmen | Position | Ende |
|---|---|---|
| ALLURION TECHNOLOGIES INC. | Corporate Officer/Principal | 31.12.2023 |
GC Aesthetics Plc
 GC Aesthetics Plc Medical SpecialtiesHealth Technology GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland. | Vertrieb & Marketing | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALLURION TECHNOLOGIES INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
GC Aesthetics Plc
GC Aesthetics Plc Medical SpecialtiesHealth Technology GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland. | Health Technology |
